《人類(lèi)基因治療》是一本涵蓋基因治療各個(gè)方面的多學(xué)科雜志。該雜志通過(guò)提供最新的研究和技術(shù)突破，對(duì)DNA、RNA和細(xì)胞療法進(jìn)行了深入報(bào)道。人類(lèi)基因治療為科學(xué)和臨床信息提供了一個(gè)中心論壇，包括倫理、法律、監(jiān)管、社會(huì)和商業(yè)問(wèn)題，使治療程序的進(jìn)步和進(jìn)步能夠改善患者的結(jié)果，并最終治愈疾病。該期刊分為三個(gè)部分。人類(lèi)基因療法是其旗艦，每年出版12期。《HGT Methods》是一本雙月刊，主要研究基因治療在產(chǎn)品檢測(cè)和開(kāi)發(fā)中的應(yīng)用。HGT臨床發(fā)展是一份季刊，作為發(fā)布與細(xì)胞和基因治療產(chǎn)品的監(jiān)管審查和商業(yè)開(kāi)發(fā)相關(guān)的數(shù)據(jù)的場(chǎng)所。完整的覆蓋范圍包括:向量發(fā)展的改善運(yùn)載系統(tǒng)細(xì)胞療法小型核酸療法，包括RNAi臨床試驗(yàn)和動(dòng)物模型臨床協(xié)議臨床前動(dòng)物和體外研究評(píng)估用于支持臨床應(yīng)用的基因和細(xì)胞治療產(chǎn)品的安全性臨床試驗(yàn)，包括結(jié)果證實(shí)性或陰性的臨床試驗(yàn)與基因和細(xì)胞治療產(chǎn)品的商業(yè)開(kāi)發(fā)相關(guān)的熱點(diǎn)問(wèn)題

Human Gene Therapy is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes in-depth coverage of DNA, RNA, and cell therapies by delivering the latest breakthroughs in research and technologies. Human Gene Therapy provides a central forum for scientific and clinical information, including ethical, legal, regulatory, social, and commercial issues, which enables the advancement and progress of therapeutic procedures leading to improved patient outcomes, and ultimately, to curing diseases.The Journal is divided into three parts. Human Gene Therapy, the flagship, is published 12 times per year. HGT Methods, a bimonthly journal, focuses on the applications of gene therapy to product testing and development. HGT Clinical Development, a quarterly journal, serves as a venue for publishing data relevant to the regulatory review and commercial development of cell and gene therapy products.Complete coverage includes: Improvements in vector developments Delivery systems Cell therapy Small nucleic acid therapeutics, including RNAi Clinical trials and animal models Clinical protocols Pre-clinical animal and in vitro studies to assess the safety of gene and cell therapy products used to support clinical applications Clinical trials including those in which the results are confirmatory or negative Topical issues related to the commercial development of gene and cell therapy products